Furthermore, culture cells mimicking HCC with CDKN3 knocked down tolerated cisplatin more than cells expressing it.[47] Thus, confirming the variation in CDKN3 expression in different types of malignancies. Here, CDKN3 is linked to hepatocellular carcinoma.